Genomic Health Inc. ‘s GHDX Oncotype DX prostate cancer test recently came under the reimbursement coverage provided by Palmetto GBA, a Medicare Administrative Contractor (MAC), following the latter’s initiation of the coverage. This will allow approximately 60,000 qualified Medicare
Medicare Initiates Coverage on Genomic Prostate Cancer Test
